Research discovers potential new Rx target for colon cancer

September 12, 2017, Louisiana State University
Credit: Louisiana State University

Genetic research conducted at LSU Health New Orleans School of Medicine and Stanley S. Scott Cancer Center demonstrated for the first time that a novel protein can cause normal cells in the lining of the colon to become malignant, grow and spread, as well as take on the characteristics of stem cells. The work, which details the process, is published online in Nature Research's Scientific Reports.

SATB2 is a novel "transcription factor" - a protein "switch" that controls which genes are turned on or off inside a cell. Drs. Rakesh Srivastava and Sharmila Shankar identified it in the so-called "cancer stem cells" - cancer cells that behave like stem cells. Cancer stem cells are a small subset of in tumors that are not only capable of renewing themselves, but also giving rise to other cells needed by the tumors to survive and grow. These cells are more resistant than typical cancer cells to standard chemotherapeutic agents and can persist in the body even after treatment. The cancer stem cells are thought to be a major cause of treatment failure, disease relapse and metastasis. Certain signals can turn a regular cancer cell into a , making it resistant to treatment. SATB2 appears to be a master regulator of that process, controlling several of the mechanisms involved.

When Drs. Srivastava and Shankar compared normal human colorectal and tissue with human colorectal cancer cell lines and primary colorectal tissues, they found that while SATB2 is not active in normal colorectal tissue, it is highly active in colorectal cancer cells.

To study SATB2's role in colorectal cancer, the researchers forced the SATB2 gene to make extra copies of the SATB2 protein in . The cells changed, displaying enhanced cell growth, motility, migration and invasion. Further analysis revealed markers and a master cell ability - the cells could produce any kind of cell needed just like other stem cells. They became cancer stem cells. The researchers also found these cells had a much greater ability to survive and proliferate.

Silencing SATB2 in the colorectal cancer cells not only suppressed cell growth, motility and colony formation, but the characteristics of cancer stem were absent. This means that if agents are identified that can block SATB2, they may be used, along with standard of care, to prevent cancer relapses and metastasis.

"Since the SATB2 protein is highly expressed in the colorectal cell lines and tissues, it can be an attractive target for therapy, diagnosis and prognosis," notes Dr. Rakesh Srivastava, Professor of Genetics at LSU Health New Orleans School of Medicine and Stanley S. Scott Cancer Center.

"Importantly, SATB2 is present not only in colon cancer, but in other cancers as well," adds Dr. Sharmila Shankar, PhD, Associate Professor of Genetics at LSU Health New Orleans School of Medicine and Stanley S. Scott Cancer Center.

Explore further: ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression

More information: Wei Yu et al, SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer, Scientific Reports (2017). DOI: 10.1038/s41598-017-05458-y

Related Stories

ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression

August 2, 2017
ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression, according to a study published August 2, 2017 in the open-access journal PLOS ONE by Varun Vijay Prabhu from Oncoceutics, Inc., USA and ...

Researchers publish new findings on influence of high-fat diet on colorectal cancer

July 6, 2017
Poor diet is associated with 80% of colorectal cancer cases, but the exact pathways by which diet leads to cancer are not known.

Potential new colorectal cancer treatment target identified

October 7, 2012
(HealthDay)—The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 (CD66c) is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, according to research ...

Researchers identify new stem cell population important in the growth of colon cancer

June 16, 2015
Researchers at Lawson Health Research Institute have identified a new stem cell population in the colon linked to cancer growth. The findings, which were recently published in the prominent journal Cell Stem Cell, will significantly ...

Metabolite that promotes cancer cell transformation and colorectal cancer spread identified

December 1, 2016
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial–mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring ...

Oral milk thistle extract stops colorectal cancer stem cells from growing tumors

April 20, 2015
In results presented at the American Association for Cancer Research (AACR) Annual Meeting 2015, a University of Colorado Cancer Center study shows that orally administering the chemical silibinin, purified from milk thistle, ...

Recommended for you

Researchers create a drug to extend the lives of men with prostate cancer

March 16, 2018
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.

Improved capture of cancer cells in blood could help track disease

March 15, 2018
Tumor cells circulating throughout the body in blood vessels have long been feared as harbingers of metastasizing cancer - even though most free-floating cancer cells will not go on to establish a new tumor.

Area surrounding a tumor impacts how breast cancer cells grow

March 14, 2018
Cancer is typically thought of as a tumor that needs to be removed or an area that needs to be treated with radiation or chemotherapy. As a physicist and cancer researcher, Joe Gray, Ph.D., thinks differently.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.